Antimicrobial Therapy Combined With C-C Chemokine Receptor Type 2 Modulation Dampens Mycobacteria-Aggravated Monocyte Activation and Atherosclerosis

CTSA https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2026.1753414/full 2026-03-30T00:00:00Z Frontiers in Cardiovascular Medicine